COVID 19 and Psychological Health: a Cross Sectional Study to Evaluate Anxiety and Depression in Covid-19 Patients

Alhasan Mujtaba Al-Mudhaffer450 enrolled

Overview

The covid-19 pandemic started to spread worldwide since December 2019. It promoted to an exaggerated psychological stress and anxiety in humans due to the intolerable symptoms higher than usual death of many infected patients. This study examines the corona related anxiety and if there is need for drug intervention to treat this anxiety. To answer these questions, a survey made to the hospitalized patients including sex, age, educational level, Marital state, and a standardized questionnaires (GAD-7 and PHQ-9) which has been validated and shown to possess good psychometric qualities in studies of participants from multiple populations.

Study Type

OBSERVATIONAL

Enrollment

450

Conditions

Covid19 Anxiety Depression

Eligibility

Sex: ALLMin age: 15 Years

Medical Language ↔ Plain English

Inclusion Criteria: \- patients with COVID19 willing to participate in the study Exclusion Criteria: * unwilling unable to read or interact with standardized questionnaire unconscious

Locations (1)

AlFayhaa Teaching hospital

Outcomes

Primary Outcomes

depression

Depression measured by Patient Health Questionnaire-9 (PHQ-9) scale. Scoring: 5-9 mild;10-14 moderate; 15-19 moderately severe; \>20 severe. Minimum 0 maximum 27 points

Time frame: at the time of acute infection, average of 1 month

anxiety

Anxiety measured by General Anxiety Disorder-7 (GAD-7) scale. Scoring:5-9 mild; 10-14 moderate; \>15 severe. Minimum 0, maximum 21 points

Time frame: at the time of acute infection, average of 1 month